The Valsartan Antihypertensive Long-Term Use Evaluation (VALUE) trial: Outcomes in patients receiving monotherapy

Julius, S; Weber, MA; Kjeldsen, SE; McInnes, GT; Zanchetti, A; Brunner, HR; Laragh, J; Schork, MA; Hua, TA; Amerena, J; Balazovjech, I; Cassel, G; Herczeg, B; Koylan, N; Magometschnigg, D; Majahalme, S; Martinez, F; Oigman, W; Gomes, RS; Zhu, JR

The Valsartan Antihypertensive Long-Term Use Evaluation (VALUE) trial: Outcomes in patients receiving monotherapy

Version 2 2024-06-13, 14:46

Version 1 2021-10-20, 16:17

journal contribution

posted on 2024-06-13, 14:46 authored by S Julius, MA Weber, SE Kjeldsen, GT McInnes, A Zanchetti, HR Brunner, J Laragh, MA Schork, TA Hua, J Amerena, I Balazovjech, G Cassel, B Herczeg, N Koylan, D Magometschnigg, S Majahalme, F Martinez, W Oigman, RS Gomes, JR Zhu

The Valsartan Antihypertensive Long-Term Use Evaluation (VALUE) trial: Outcomes in patients receiving monotherapy

History

Journal

Hypertension

Volume

48

Pagination

385-391

Location

United States

Publisher DOI

https://doi.org/10.1161/01.HYP.0000236119.96301.f2

Link to full text

https://www.ahajournals.org/doi/pdf/10.1161/01.HYP.0000236119.96301.f2

ISSN

0194-911X

eISSN

1524-4563

Language

en

Publication classification

C1.1 Refereed article in a scholarly journal

Issue

3

Publisher

Ovid Technologies (Wolters Kluwer Health)

Usage metrics

Licence

Exports

RefWorks

BibTeX

Ref. manager

Endnote

DataCite

NLM

DC

The Valsartan Antihypertensive Long-Term Use Evaluation (VALUE) trial: Outcomes in patients receiving monotherapy

History

Journal

Volume

Pagination

Location

Publisher DOI

Link to full text

ISSN

eISSN

Language

Publication classification

Issue

Publisher

Usage metrics

Categories

Keywords

Licence

Exports